| European Respiratory Society guidelines for the management of adult bronchiectasis E Polverino, PC Goeminne, MJ McDonnell, S Aliberti, SE Marshall, ... European Respiratory Journal 50 (3), 2017 | 1059 | 2017 |
| Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial A Torres, O Sibila, M Ferrer, E Polverino, R Menendez, J Mensa, ... Jama 313 (7), 677-686, 2015 | 641 | 2015 |
| Microbial aetiology of community-acquired pneumonia and its relation to severity C Cillóniz, S Ewig, E Polverino, MA Marcos, C Esquinas, A Gabarrús, ... Thorax 66 (4), 340-346, 2011 | 410 | 2011 |
| Etiology of non–cystic fibrosis bronchiectasis in adults and its correlation to disease severity S Lonni, JD Chalmers, PC Goeminne, MJ McDonnell, K Dimakou, ... Annals of the American Thoracic Society 12 (12), 1764-1770, 2015 | 339 | 2015 |
| Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research AT Hill, CS Haworth, S Aliberti, A Barker, F Blasi, W Boersma, ... European Respiratory Journal 49 (6), 2017 | 337 | 2017 |
| Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations S Ahmedzai, IM Balfour-Lynn, T Bewick, R Buchdahl, RK Coker, ... Thorax 66 (Suppl 1), i1-i30, 2011 | 271 | 2011 |
| Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study R Wilson, T Welte, E Polverino, A De Soyza, H Greville, A O'Donnell, ... European Respiratory Journal 41 (5), 1107-1115, 2013 | 245 | 2013 |
| Characterization of the “frequent exacerbator phenotype” in bronchiectasis JD Chalmers, S Aliberti, A Filonenko, M Shteinberg, PC Goeminne, ... American journal of respiratory and critical care medicine 197 (11), 1410-1420, 2018 | 242 | 2018 |
| Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission A Liapikou, M Ferrer, E Polverino, V Balasso, M Esperatti, R Piñer, ... Clinical Infectious Diseases 48 (4), 377-385, 2009 | 237 | 2009 |
| Impact of age and comorbidity on cause and outcome in community-acquired pneumonia C Cillóniz, E Polverino, S Ewig, S Aliberti, A Gabarrús, R Menéndez, ... Chest 144 (3), 999-1007, 2013 | 235 | 2013 |
| Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration S Aliberti, S Masefield, E Polverino, A De Soyza, MR Loebinger, ... European Respiratory Journal 48 (3), 632-647, 2016 | 204 | 2016 |
| The role of neutrophil elastase inhibitors in lung diseases E Polverino, E Rosales-Mayor, GE Dale, K Dembowsky, A Torres Chest 152 (2), 249-262, 2017 | 198 | 2017 |
| Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia E Prina, OT Ranzani, E Polverino, C Cillóniz, M Ferrer, L Fernandez, ... Annals of the American Thoracic Society 12 (2), 153-160, 2015 | 198 | 2015 |
| The EMBARC European Bronchiectasis Registry: protocol for an international observational study JD Chalmers, S Aliberti, E Polverino, M Vendrell, M Crichton, M Loebinger, ... ERJ open research 2 (1), 2016 | 197 | 2016 |
| The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions E Polverino, K Dimakou, J Hurst, MA Martinez-Garcia, M Miravitlles, ... European Respiratory Journal 52 (3), 2018 | 190 | 2018 |
| Bronchiectasis in India: results from the European multicentre bronchiectasis audit and research collaboration (EMBARC) and respiratory research network of India registry R Dhar, S Singh, D Talwar, M Mohan, SK Tripathi, R Swarnakar, S Trivedi, ... The Lancet Global Health 7 (9), e1269-e1279, 2019 | 187 | 2019 |
| The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis D Araújo, M Shteinberg, S Aliberti, PC Goeminne, AT Hill, TC Fardon, ... European Respiratory Journal 51 (2), 2018 | 184 | 2018 |
| RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis T Aksamit, A De Soyza, TJ Bandel, M Criollo, JS Elborn, E Operschall, ... European Respiratory Journal 51 (1), 2018 | 178 | 2018 |
| RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis A De Soyza, T Aksamit, TJ Bandel, M Criollo, JS Elborn, E Operschall, ... European Respiratory Journal 51 (1), 2018 | 175 | 2018 |
| Spanish guidelines on treatment of bronchiectasis in adults MÁ Martínez-García, L Máiz, C Olveira, RM Girón, D de la Rosa, M Blanco, ... Archivos de Bronconeumología (English Edition) 54 (2), 88-98, 2018 | 167 | 2018 |
Torres AHospital Clinic Barcelona, Unversidad de Barcelona, Ciberes, IdibapsVerified email at ub.edu
